학술논문
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma
Document Type
article
Author
Source
eJHaem, Vol 4, Iss 4, Pp 921-926 (2023)
Subject
Language
English
ISSN
2688-6146
Abstract
Abstract Lymphoma is one of the most common cancers in adolescents and young adults, but historically, this population has had lower clinical trial enrollment and improvements in overall survival as compared to other age populations. There are multiple challenges that are unique to this population that have affected drug development and clinical trial enrollment. Our panel of experts have identified barriers, and in this review, we discuss current methods to address these barriers as well as potential solutions moving forward.